HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit
1:39:35 Apr 21, 2025
About this episode
Clinical investigators discuss available data guiding the management of HER2-positive, triple-negative and localized breast cancer. CME information and select publications here.